• Chemung Financial Corp (NASDAQ:CHMG) exceeded Zacks Consensus Estimate with an EPS of $1.61.
• The company's revenue for the quarter was $30.59 million, surpassing estimates by 5.11%.
• Annual net income reported was $15.1 million, with a notable $17.5 million loss on the sale of securities.

Chemung Financial Corp (NASDAQ:CHMG), a key player in the Zacks Banks - Southeast industry, has recently made headlines with its strong financial performance in the fourth quarter. The company, operating through its subsidiary, Chemung Canal Trust Company, has shown a remarkable ability to exceed market expectations.

On February 2, 2026, Tyrrell Thomas R., a director at Chemung Financial, sold 500 shares of the company's common stock at $61 each, retaining around 8,800 shares post-transaction. This move came shortly after the company announced its fourth-quarter earnings, which were slightly above the Zacks Consensus Estimate with an EPS of $1.61, compared to last year's $1.24 EPS for the same quarter. The earnings surprise of +0.63% underscores the company's operational efficiency and market foresight.

Revenue figures were also impressive, with Chemung Financial posting $30.59 million for the quarter ending December 2025, a significant increase from the $25.88 million reported in the previous year. This 5.11% beat against the Zacks Consensus Estimate marks a notable achievement, although it's important to note that the company has only exceeded consensus revenue estimates once in the last four quarters.

The company's net income for the fourth quarter stood at $7.7 million, or $1.61 per share, showcasing a steady performance despite a slight decrease from the third quarter's $7.8 million, or $1.62 per share. Yearly figures were also strong, with a net income of $15.1 million, or $3.14 per share, which includes a significant $17.5 million loss on the sale of securities.

Chemung Financial's valuation and profitability metrics, such as a P/E ratio of approximately 19.93, a price-to-sales ratio of about 2.25, and an enterprise value to sales ratio of around 2.08, offer investors a comprehensive view of the company's financial health. The enterprise value to operating cash flow ratio stands at approximately 7.83, with an earnings yield of about 5.02%, further highlighting the company's robust financial standing.